Nspiremed provides an AI‑assisted nasal cannula for neonatal intensive care that continuously monitors an infant’s oxygen saturation and breathing patterns with embedded biosensors. The system automatically adjusts pressure and oxygen flow in real time to keep infants within the optimal oxygenation window, reducing hypoxia risk, shortening NICU stays, and easing nurses’ monitoring workload.
Funding
Funding not disclosed
Founders
Product
Problem
Infants in neonatal intensive care often require supplemental oxygen, but traditional nasal cannulas provide static flow rates that cannot adapt to the infant’s changing respiratory needs during feeding, sleep, or handling, leading to periods of suboptimal oxygenation and increased risk of complications.
Solution
Nspire offers an AI‑assisted nasal cannula designed specifically for neonatal patients. The cannula incorporates embedded biosensors that continuously monitor the infant’s oxygen saturation and breathing patterns. Using real‑time data, the system automatically adjusts pressure and oxygen flow to keep the infant within the optimal oxygenation window. This adaptive delivery reduces the likelihood of hypoxia or hyperoxia, supports healthier growth, shortens NICU stays, and lessens the monitoring workload for nurses.
Target Audience
Primary customers are neonatal intensive care units, hospitals, and clinicians caring for preterm or critically ill infants who require precise supplemental oxygen therapy.
Features
- Integrated biosensors that track oxygen saturation and respiratory metrics continuously
- AI-driven algorithm that dynamically modulates oxygen flow and pressure in response to real‑time infant needs
- Designed as a lightweight, infant‑friendly nasal cannula to minimize discomfort and skin irritation
- Cloud‑enabled data logging for trend analysis and remote clinician review
- Compatibility with standard hospital oxygen supply systems and easy integration into existing NICU workflows